Worth reading
64In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
2080
¥ million (net sales target for the fiscal year ending March 2029)Wording
Avoiding a definitive answer
How definitive the wording is.Items stated in the management plan
FormulatedNet Sales+303.1%
基準 516Target2,080million
Operating profit+114.3%
基準 -1,360Target195million
Net income for the current fiscal year+105.5%
基準 -2,415Target132million
Each line is the climb from the baseline the document states to the target it sets. The slope is scaled against the largest climb in this document. The increase shown by the dotted line is calculated from the two reported figures because the company did not provide the amount of growth.
Operating profit margin-259.6 % → Not disclosed
ROE-94.3 % → Not disclosed
Only the target level is shown because the current level for comparison was not provided.What happened to the previous planDevelop 2-inch mosaic wafers by the end of the fiscal year → Mosaic crystals completed in May 2026+101,200.0%Calculated from the two disclosed figures
Total investment plantotal ¥3,965 million
Investment amount by sectorField Development investment in 2-inch single-crystal wafers / Amount ¥670 million / Scheduled timing of expenditures August 2026 to March 2028, Field Development investment in 4-inch mosaic wafers / Amount ¥810 million / Scheduled timing of expenditures October 2027 to March 2029, Field Development investment in 2-inch low-resistivity wafers / Amount ¥830 million / Scheduled timing of expenditures January 2027 to October 2028, Field Increasing production of lab-grown diamond rough stones and establishing a gemstone sales structure / Amount ¥800 million / Scheduled timing of expenditures July 2027 to May 2029, Field Expansion and construction of development and manufacturing facilities / Amount ¥855 million / Scheduled timing of expenditures August 2027 to December 2028
Key initiatives
01Create markets for device wafers and related products
02Revitalize the seed crystal business and expand sales of gemstones and other products
03Strategy for diamond wafers
04Approach to the lab-grown diamond (LGD) business
05Strategy for the substrate and wafer fields
06Strategy for the LGD field
Segment targetSegment Seed crystals / Sales target Fiscal year ending March 2027 527 / Fiscal year ending March 2028 550 / Fiscal year ending March 2029 550 / Profit Target Not disclosed, Segment Gemstones and other products / Sales target Fiscal year ending March 2027 73 / Fiscal year ending March 2028 180 / Fiscal year ending March 2029 350 / Profit Target Not disclosed, Segment Device-related products / Sales target Fiscal year ending March 2027 463 / Fiscal year ending March 2028 750 / Fiscal year ending March 2029 1,100 / Profit Target Not disclosed, Segment Other / Sales target Fiscal year ending March 2027 37 / Fiscal year ending March 2028 50 / Fiscal year ending March 2029 80 / Profit Target Not disclosed
Non-financial targetsIndicator name Commercialization of 2-inch mosaic wafers / Target value Product development / Timing Scheduled for release in October 2026, Indicator name Single-crystal size / Target value Development of 50x50 mm crystals / Timing By March 2028, Indicator name 4-inch mosaic wafers / Target value Development of 4-inch mosaic wafers / Timing Not disclosed
Risks identified by the company
Failure to comply correctly with trade control regulations
Delays in device development
Failure of seed crystal sales to recover
Dependence on President Fujimori (藤森)
Inability to secure sufficient personnel
Reason for revision or withdrawal
The top priority is recovering from the substantial decline in sales over the past 3 years. Substantial losses have continued for 3 years, making an urgent recovery necessary.
| Item | Details |
|---|---|
| Plan name | Medium-Term Management Plan (Growth Strategy) |
| Plan period | Fiscal years ending March 2027 to March 2029 |
| Progress against the plan | Formulated |
| Sales Target | ¥516 million → ¥2,080 million |
| Operating profit target | ¥-1,360 million → ¥195 million |
| Operating profit margin target | -259.6 % → Not disclosed |
| Net income target | ¥-2,415 million → ¥132 million |
| ROE target | -94.3 % → Not disclosed |
| Total investment plan | total ¥3,965 million |
| Investment amount by sector | Field Development investment in 2-inch single-crystal wafers / Amount ¥670 million / Scheduled timing of expenditures August 2026 to March 2028, Field Development investment in 4-inch mosaic wafers / Amount ¥810 million / Scheduled timing of expenditures October 2027 to March 2029, Field Development investment in 2-inch low-resistivity wafers / Amount ¥830 million / Scheduled timing of expenditures January 2027 to October 2028, Field Increasing production of lab-grown diamond rough stones and establishing a gemstone sales structure / Amount ¥800 million / Scheduled timing of expenditures July 2027 to May 2029, Field Expansion and construction of development and manufacturing facilities / Amount ¥855 million / Scheduled timing of expenditures August 2027 to December 2028 |
| Segment target | Segment Seed crystals / Sales target Fiscal year ending March 2027 527 / Fiscal year ending March 2028 550 / Fiscal year ending March 2029 550 / Profit Target Not disclosed, Segment Gemstones and other products / Sales target Fiscal year ending March 2027 73 / Fiscal year ending March 2028 180 / Fiscal year ending March 2029 350 / Profit Target Not disclosed, Segment Device-related products / Sales target Fiscal year ending March 2027 463 / Fiscal year ending March 2028 750 / Fiscal year ending March 2029 1,100 / Profit Target Not disclosed, Segment Other / Sales target Fiscal year ending March 2027 37 / Fiscal year ending March 2028 50 / Fiscal year ending March 2029 80 / Profit Target Not disclosed |
| Non-financial targets | Indicator name Commercialization of 2-inch mosaic wafers / Target value Product development / Timing Scheduled for release in October 2026, Indicator name Single-crystal size / Target value Development of 50x50 mm crystals / Timing By March 2028, Indicator name 4-inch mosaic wafers / Target value Development of 4-inch mosaic wafers / Timing Not disclosed |
| Key initiatives | Create markets for device wafers and related products, Revitalize the seed crystal business and expand sales of gemstones and other products, Strategy for diamond wafers, Approach to the lab-grown diamond (LGD) business, Strategy for the substrate and wafer fields, Strategy for the LGD field |
| Results under the previous plan | Develop 2-inch mosaic wafers by the end of the fiscal year → Mosaic crystals completed in May 2026 |
| Reason for revision or withdrawal | The top priority is recovering from the substantial decline in sales over the past 3 years. Substantial losses have continued for 3 years, making an urgent recovery necessary. |
| Risks identified | Failure to comply correctly with trade control regulations, Delays in device development, Failure of seed crystal sales to recover, Dependence on President Fujimori (藤森), Inability to secure sufficient personnel |
| Publication date | 30 June 2026 |
Items this document does not state (8)
ROIC targetPayout ratio / DOE policyTreasury share acquisition policyCost of capitalSelf-assessment of PBR and share pricePlan assumptionsSize of the Target MarketDate of board resolution
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The top priority is recovering from the substantial decline in sales over the past 3 years, and an urgent recovery is also needed from the substantial losses that have continued for 3 years. The company plans to significantly improve its cost structure by continuing to expand sales and implement cost-cutting measures.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.